PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation

NCT02475798 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2020-12-16

No results posted yet for this study

Summary

The purpose of this extended study is to collect confirmatory safety and effectiveness data on the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in the treatment of aortoiliac and iliac aneurysms.

Conditions

  • Aortoiliac Aneurysms
  • Iliac Aneurysms

Interventions

DEVICE

Zenith® Branch Endovascular Graft-Iliac Bifurcation,

Implantation of the following devices: Zenith® Branch Endovascular Graft-Iliac Bifurcation, the Atrium iCAST™, and the Zenith® Flex AAA Endovascular Graft.

Sponsors & Collaborators

  • Cook Research Incorporated

    lead INDUSTRY

Principal Investigators

  • W. Anthony Lee, MD · Christine E. Lynn Heart and Vascular Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02475798 on ClinicalTrials.gov